Related Experiment Video
Updated: Jul 19, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against
Xiuran Wang1, Peng Li1, Amit K Singh1
1Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208.
Abstract:
SignificanceYersinia pestis, the etiologic agent of plague, has been responsible for high mortality in several epidemics throughout human history. This plague bacillus has been used as a biological weapon during human history and is currently one of the deadliest biological threats. Currently, no licensed plague vaccines are available in the Western world. Since an array of immunogens are enclosed in outer membrane vesicles (OMVs), immune responses elicited by OMVs against a diverse range of antigens may reduce the likelihood of antigen circumvention. Therefore, self-adjuvanting OMVs from a remodeled Yersinia pseudotuberculosis strain as a type of plague vaccine could diversify prophylactic choices and solve current vaccine limitations.
Insights
This study explores a novel plague vaccine using outer membrane vesicles (OMVs) from a modified Yersinia pseudotuberculosis strain. This approach aims to provide a new prophylactic option against Yersinia pestis, the deadly plague bacterium.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Yersinia pestis causes plague, a historically devastating disease with no licensed vaccines in Western countries.
- The bacterium is considered a significant biological threat due to its potential for weaponization and high mortality.
- Current limitations in plague prophylaxis necessitate the development of new vaccine strategies.
Purpose of the Study:
- To investigate the potential of self-adjuvanting outer membrane vesicles (OMVs) from a remodeled Yersinia pseudotuberculosis strain as a plague vaccine.
- To explore OMVs as a platform for eliciting immune responses against diverse Yersinia pestis antigens.
- To address the limitations of current vaccine options for plague prevention.
Main Methods:
- Development of a remodeled Yersinia pseudotuberculosis strain engineered to produce self-adjuvanting OMVs.
- Characterization of the immunogenic properties of the generated OMVs.
- Evaluation of the potential of these OMVs to induce protective immunity against Yersinia pestis.
Main Results:
- The study demonstrates the feasibility of using remodeled Yersinia pseudotuberculosis OMVs as a vaccine candidate.
- OMVs contain a variety of antigens that can potentially elicit broad immune responses.
- This OMV-based approach offers a promising strategy to overcome existing vaccine limitations.
Conclusions:
- Self-adjuvanting OMVs from a remodeled Yersinia pseudotuberculosis strain represent a viable and innovative approach for a plague vaccine.
- This strategy could diversify prophylactic choices and enhance protection against Yersinia pestis infections.
- Further research and development are warranted to advance this OMV-based vaccine towards clinical application.
Related Concept Videos
Vaccine Production
Regulation of Bacterial Virulence
Plague

